| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |